BioNTech SE

Companies mass producing shots for Pfizer, Moderna and AstraZeneca are racing to find staff: ‘We are truly in unprecedented territory’

Johnson & Johnson said it has enrolled about 45,000 participants for the first late-stage trial of its Covid-19 single-dose vaccine candidate.

Company will provide 100 million more doses to bolster campaign under way in U.S.

Second major U.S. coronavirus vaccine could possibly be shipped by this weekend.

FDA Commissioner Stephen Hahn tweeted Friday that the agency “is finalizing the necessary documents to ensure that patients and providers have the information that they need to make informed decisions.”

The Food and Drug Administration said the first Covid-19 vaccine being considered for U.S. distribution “met the prescribed success criteria” in a clinical study, paving the way for the agency to green-light distribution as early as this weekend.

BioNTech's BNTX.O co-founder and chief executive said he was optimistic that the protective effect of its experimental COVID-19 vaccine, co-developed with Pfizer PFE.N, would last for at least a year.

The U.S. pharmaceutical giant is preparing to ship billions of Covid-19 vaccines using frozen boxes, cargo planes and trucks in a mega logistics operation.

Company also released the guidelines for the shot’s final-stage trial.

Nine chief executives issued an extraordinary joint statement Tuesday seeking to bolster faith in coronavirus vaccine.